Document 0943
 DOCN  M9440943
 TI    Magnetic resonance imaging in demyelinating, infectious, metabolic, and
       congenital diseases.
 DT    9404
 AU    Mechtler LL; Kinkel PR; Division of Neuroimaging Research, Millard
       Fillmore Hospitals,; Lucy Dent Imaging Center, Buffalo, NY 14209.
 SO    Curr Opin Neurol. 1993 Dec;6(6):912-8. Unique Identifier : AIDSLINE
       MED/94122918
 AB    A mere 5 to 7 years ago, the majority of literature on demyelinating,
       infectious, metabolic, and congenital diseases of the brain focused on
       comparison between computed tomography and magnetic resonance imaging
       (MRI). MRI has become not only the foremost diagnostic tool in imaging
       of the central nervous system, but also a key research instrument. This
       is displayed by the recent increase in papers concerning magnetic
       resonance spectroscopy. It is perhaps no better illustrated than in the
       study of multiple sclerosis. A review of neuroimaging in infectious
       diseases places a heavy emphasis on AIDS-related infections. The ongoing
       development of new scan sequences, contrast agents, and fast scanning
       techniques are broadening our image of the brain and, indeed, our
       understanding of pathophysiologic mechanisms of disease states.
       Excellent examples of this are the metabolic and congenital diseases
       where, based on the knowledge of metabolic pathways and embryology, MRI
       has become the modality of choice.
 DE    AIDS Dementia Complex/*DIAGNOSIS  AIDS-Related Opportunistic
       Infections/*DIAGNOSIS  Brain/ABNORMALITIES/PATHOLOGY  Brain
       Diseases/*CONGENITAL/DIAGNOSIS  Brain Diseases, Metabolic/*DIAGNOSIS
       Demyelinating Diseases/*DIAGNOSIS  Human  *Magnetic Resonance Imaging
       Multiple Sclerosis/DIAGNOSIS  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).